Septic arthritis (peds): Difference between revisions
| (25 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
== Background == | ''This page is for <u>pediatric</u> patients; for adult patients see [[septic arthritis]].'' | ||
==Background== | |||
*Most often in | *Most often in patients < 3yo | ||
*MSSA and MRSA are most common causes in all age groups | *MSSA and MRSA are most common causes in all age groups | ||
* | *Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk | ||
==Clinical Features== | |||
*Neonates | *Neonates | ||
**Do not appear ill | **Do not appear ill | ||
| Line 16: | Line 15: | ||
**WBC >12K | **WBC >12K | ||
== | ==Differential Diagnosis== | ||
*[[Trauma]] | |||
*[[Septic arthritis]] | |||
*[[Acute Rheumatic Fever]] | |||
*[[Reactive Arthritis (Poststreptococcal)]] | |||
*Gonococcal arthritis | |||
*[[Lyme disease]] | |||
*[[Sickle cell crisis]] | |||
*[[Henoch-Schonlein Purpura (HSP)]] | |||
*[[Legg Calve Perthes Disease]] | |||
*[[Slipped Capital Femoral Epiphysis (SCFE)]] | |||
*[[Osteomyelitis]] | |||
*[[Juvenile Idiopathic Arthritis]] | |||
*[[Transient (Toxic) Synovitis (Hip)]] | |||
*[[Hemophilia]] | |||
*[[Osgood Schlatter Disease]] | |||
==Evaluation== | |||
===Work-Up=== | |||
*Labs | *Labs | ||
**CBC | **CBC, ESR, CRP, , blood/throat cultures | ||
*Arthrocentesis | *[[Arthrocentesis]] | ||
**Cell count, | **Cell count, gram stain, glucose, cultures | ||
== | ===Kocher Criteria=== | ||
*One point each | |||
**Non-weight bearing on affected side | |||
**ESR >40mm/hr | |||
**Fever | |||
**WBC >12,000 | |||
*Probability by points<ref> Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.</ref> | |||
**1 of 4 - 3% | |||
**2 of 4 - 40% | |||
**3 of 4 - 93% | |||
**4 of 4 - 99% | |||
#Joint drainage | ==Management== | ||
#IV | #Joint drainage/wash out | ||
#IV [[antibiotics]] | |||
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | ||
| Line 60: | Line 69: | ||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Clindamycin]], 10 milligrams/kg every 6–8 h | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Clindamycin]], 10 milligrams/kg every 6–8 h | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ||
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="5" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Group B | | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="5" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Group B Streptococcus]] | ||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Ampicillin]], 50–100 milligrams/kg every 6 h | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Ampicillin]], 50–100 milligrams/kg every 6 h | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ||
| Line 88: | Line 97: | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Gram-Negative]] bacilli | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Gram-Negative]] bacilli | ||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Cefotaxime or ceftriaxone (dosing as above) | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Cefotaxime or [[ceftriaxone]] (dosing as above) | ||
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ||
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''Haemophilus influenzae'' | | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''Haemophilus influenzae'' | ||
| Line 113: | Line 122: | ||
|} | |} | ||
== Disposition == | ==Disposition== | ||
Admit | *Admit | ||
==See Also== | ==See Also== | ||
[[Septic Arthritis (General)]] | *[[Septic Arthritis (General)]] | ||
*[[Arthrocentesis]] | |||
[[Arthrocentesis]] | *[[Septic arthritis of the hip (peds)]] | ||
==References== | |||
<references/> | |||
[[Category: | [[Category:Pediatrics]] | ||
[[Category: | [[Category:Orthopedics]] | ||
[[Category:ID]] | [[Category:ID]] | ||
Latest revision as of 19:29, 22 October 2020
This page is for pediatric patients; for adult patients see septic arthritis.
Background
- Most often in patients < 3yo
- MSSA and MRSA are most common causes in all age groups
- Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk
Clinical Features
- Neonates
- Do not appear ill
- Only 50% have fever
- Older infants, toddlers, children
- Fever (>101.3), localizing signs
- Labs
- CRP >20
- WBC >12K
Differential Diagnosis
- Trauma
- Septic arthritis
- Acute Rheumatic Fever
- Reactive Arthritis (Poststreptococcal)
- Gonococcal arthritis
- Lyme disease
- Sickle cell crisis
- Henoch-Schonlein Purpura (HSP)
- Legg Calve Perthes Disease
- Slipped Capital Femoral Epiphysis (SCFE)
- Osteomyelitis
- Juvenile Idiopathic Arthritis
- Transient (Toxic) Synovitis (Hip)
- Hemophilia
- Osgood Schlatter Disease
Evaluation
Work-Up
- Labs
- CBC, ESR, CRP, , blood/throat cultures
- Arthrocentesis
- Cell count, gram stain, glucose, cultures
Kocher Criteria
- One point each
- Non-weight bearing on affected side
- ESR >40mm/hr
- Fever
- WBC >12,000
- Probability by points[1]
- 1 of 4 - 3%
- 2 of 4 - 40%
- 3 of 4 - 93%
- 4 of 4 - 99%
Management
- Joint drainage/wash out
- IV antibiotics
| Age | Suspected Organism | Antibiotics |
|---|---|---|
| Newborn (0–2 mo) | Staphylococcus aureus | Vancomycin, 10 milligrams/kg every 6–8 h |
| or | ||
| Clindamycin, 10 milligrams/kg every 6–8 h | ||
| Group B Streptococcus | Ampicillin, 50–100 milligrams/kg every 6 h | |
| and | ||
| Cefotaxime, 50 milligrams/kg every 6–8 h | ||
| or | ||
| Ceftriaxone, 50 milligrams/kg every 12 h | ||
| Gram-negative bacilli | Cefotaxime, 50 milligrams/kg every 8 h | |
| Neisseria gonorrhoeae | Cefotaxime, 50 milligrams/kg every 8 h | |
| Unknown | Vancomycin or clindamycin and cefotaxime or ceftriaxone (dosing as above) | |
| Infant (2–36 mo) | S. aureus | Vancomycin or clindamycin (dosing as above) |
| Streptococcus species | Clindamycin/cefotaxime/ceftriaxone (dosing as above) | |
| Gram-Negative bacilli | Cefotaxime or ceftriaxone (dosing as above) | |
| Haemophilus influenzae | Cefotaxime or ceftriaxone (dosing as above) | |
| Unknown | Vancomycin or clindamycin and cefotaxime or ceftriaxone | |
| Child (>36 mo) | S. aureus | Vancomycin or clindamycin |
| Streptococcus species | Clindamycin/cefotaxime/ceftriaxone | |
| Gram-negative bacilli | Cefotaxime or ceftriaxone | |
| N. gonorrhoeae | Cefotaxime or ceftriaxone | |
| Unknown | Vancomycin or clindamycin and cefotaxime or ceftriaxone |
Disposition
- Admit
See Also
References
- ↑ Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.
